Logo
International Journal of
Research in Pharmacy and Pharmaceutical Sciences
ARCHIVES
VOL. 11, ISSUE 3 (2026)
Development and validation of a stability-indicating RP-UPLC method for the estimation of loxapine in bulk drug and pharmaceutical dosage form
Authors
Narasimha Rao B V, Prasada Rao M, Gayathri Devi K, Udaya Krishna Veni A, Azuma Shaik
Abstract
A rapid and reliable ultra-performance liquid chromatographic (UPLC) method was developed and validated for the quantitative estimation of Loxapine in bulk drug and pharmaceutical dosage form. The method was developed using a Waters ACQUITY UPLC H-Class system equipped with a photodiode array detector. Chromatographic separation was achieved on an ACQUITY BEH C18 column (2.1 × 50 mm, 1.7 µm) using acetonitrile and phosphate buffer (pH 3.0) containing 0.1% triethylamine in a 65:35 (v/v) ratio as the mobile phase. The flow rate was 0.3 mL/min, detection was performed at 254 nm, injection volume was 2 µL, and the total run time was 8 min. Loxapine showed a retention time of 3.898 min with 4596 theoretical plates and a tailing factor of 0.87. The method was validated for system suitability, specificity, sensitivity, linearity, precision, accuracy, ruggedness, robustness, and forced degradation. Linearity was established over 2.5–15 µg/mL with r² = 0.99978. The LOD and LOQ were 0.257 and 0.777 µg/mL, respectively. Accuracy studies showed recoveries of 98.50–99.06% with %RSD values below 2%. System precision and method precision showed %RSD values of 0.71% and 0.70%, respectively. The method demonstrated acceptable ruggedness and robustness. Forced degradation showed maximum degradation under acid stress (4.45%), followed by alkali (3.55%) and oxidative stress (3.20%), while neutral hydrolysis, thermal, and photolytic conditions produced comparatively lower degradation. The assay was 98.92% for the bulk drug and 99.99% of label claim for the marketed capsule formulation. The developed method was therefore found to be suitable for routine quantitative analysis of Loxapine in bulk drug and pharmaceutical dosage form.
Download
Pages:59-62
How to cite this article:
Narasimha Rao B V, Prasada Rao M, Gayathri Devi K, Udaya Krishna Veni A, Azuma Shaik "Development and validation of a stability-indicating RP-UPLC method for the estimation of loxapine in bulk drug and pharmaceutical dosage form". International Journal of Research in Pharmacy and Pharmaceutical Sciences, Vol 11, Issue 3, 2026, Pages 59-62

Please enter the email address corresponding to this article submission.

Development and validation of a stability-indicating RP-UPLC method for the estimation of loxapine in bulk drug and pharmaceutical dosage form | International Journal of Research in Pharmacy and Pharmaceutical Sciences